STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes

Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that const...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 102; no. 19; pp. 6948 - 6953
Main Authors Zhang, Qian, Wang, Hong Y., Marzec, Michal, Raghunath, Puthiyaveettil N., Nagasawa, Tomohiko, Wasik, Mariusz A., Nowell, Peter C.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 10.05.2005
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies.
AbstractList Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies.
Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo . Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies.
Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo . Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. DNMT1 SHP-1 STAT3
Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the SHP-1 promoter by a currently undefined mechanism. We demonstrate that malignant T cells express DNA methyltransferase (DNMT) 1 and that constantly activated signal transducer and activator of transcription (STAT) 3 is capable of binding in vitro to DNA oligonucleotides corresponding to four STAT3 SIE/GAS binding sites identified in the SHP-1 promoter. STAT3, DNMT1, and histone deacetylase 1 form complexes and bind to the SHP-1 promoter in vivo. Treatment with pharmacologic grade DNMT1 anti-sense oligonucleotides and STAT3 small-interfering RNA induces in the malignant T cells DNA demethylation and expression of SHP-1 gene. These data indicate that STAT3 may, in part, transform cells by inducing epigenetic silencing of SHP-1 in cooperation with DNMT1 and, apparently, histone deacetylase 1. Reversal of such gene silencing represents an attractive aim for novel anticancer therapies. [PUBLICATION ABSTRACT]
Author Marzec, Michal
Nowell, Peter C.
Wang, Hong Y.
Zhang, Qian
Nagasawa, Tomohiko
Wasik, Mariusz A.
Raghunath, Puthiyaveettil N.
AuthorAffiliation Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104
AuthorAffiliation_xml – name: Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104
Author_xml – sequence: 1
  givenname: Qian
  surname: Zhang
  fullname: Zhang, Qian
– sequence: 2
  givenname: Hong Y.
  surname: Wang
  fullname: Wang, Hong Y.
– sequence: 3
  givenname: Michal
  surname: Marzec
  fullname: Marzec, Michal
– sequence: 4
  givenname: Puthiyaveettil N.
  surname: Raghunath
  fullname: Raghunath, Puthiyaveettil N.
– sequence: 5
  givenname: Tomohiko
  surname: Nagasawa
  fullname: Nagasawa, Tomohiko
– sequence: 6
  givenname: Mariusz A.
  surname: Wasik
  fullname: Wasik, Mariusz A.
– sequence: 7
  givenname: Peter C.
  surname: Nowell
  fullname: Nowell, Peter C.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/15870198$$D View this record in MEDLINE/PubMed
BookMark eNqFkk9v0zAYxi00xLrCmQsCiwPiks3_EscXpGqMDamFSQ1ny0mc1lVqZ7GDyKfgK-Oo1Qoc4GRL_j2P3_fRcwHOrLMagJcYXWLE6VVnlb9EKcIiFRiRJ2CGkcBJxgQ6AzOECE9yRtg5uPB-hxASaY6egXOc5jxq8hn4uS4WBU2gsjX8-GUBVzpsxzb0yvpG98priJOVro0KuoY3ndloq4Op4Nq02lbGbqBr4PruPsGwGHvnjdXwfut8t1VhUhfD3vVwPXRdr72P19toAI2FK9WajVU2wAIux323ddUYtH8Onjaq9frF8ZyDb59uiuu7ZPn19vP1YplUKeEhESXFNWO4VmWGMsHShog6S_MqE7zJCRaIlpRkGDFNy5rULC1rjCvFOUOM5ojOwYeDbzeUe11X2sadW9n1Zq_6UTpl5J8v1mzlxn2XGCPEcxoN3h0NevcwaB_k3vhKt62y2g1eZjyOwQj-L4h5RgiJlnPw9i9w54bexhQkQZhyIfj07dUBqmLYvtfN48gYyakScqqEPFUiKl7_vumJP3YgAm-OwKQ82RGJhYzZTsT7fxOyGdo26B8hoq8O6M4H1z-ylPKUZZj-AuzI1UI
CitedBy_id crossref_primary_10_1073_pnas_1205132109
crossref_primary_10_4049_jimmunol_1100573
crossref_primary_10_1038_nrm2039
crossref_primary_10_1186_1476_4598_12_50
crossref_primary_10_1016_j_cell_2014_07_031
crossref_primary_10_1038_s41419_020_02934_8
crossref_primary_10_1016_j_smim_2006_03_013
crossref_primary_10_2174_1568009622666220301105214
crossref_primary_10_1146_annurev_immunol_26_021607_090418
crossref_primary_10_1155_2015_178698
crossref_primary_10_3390_ijms20092256
crossref_primary_10_1016_j_it_2023_09_005
crossref_primary_10_1189_jlb_0312126
crossref_primary_10_3390_biom9120875
crossref_primary_10_1186_s13148_020_00962_x
crossref_primary_10_1007_s10620_012_2152_1
crossref_primary_10_1016_j_neuron_2007_04_019
crossref_primary_10_5858_2010_0507_RAR_1
crossref_primary_10_1002_jcb_20838
crossref_primary_10_1111_imr_12172
crossref_primary_10_1186_s13148_018_0450_y
crossref_primary_10_4049_jimmunol_180_9_5898
crossref_primary_10_1038_nri2958
crossref_primary_10_1111_bjh_15763
crossref_primary_10_3390_cancers12103037
crossref_primary_10_4049_jimmunol_2000234
crossref_primary_10_1007_s11864_024_01202_7
crossref_primary_10_1016_j_jgg_2020_04_006
crossref_primary_10_3389_fimmu_2018_01886
crossref_primary_10_1161_JAHA_117_007572
crossref_primary_10_1152_ajpheart_00570_2012
crossref_primary_10_1016_j_ygyno_2006_10_003
crossref_primary_10_1038_s41375_023_02038_0
crossref_primary_10_1158_0008_5472_CAN_18_0359
crossref_primary_10_1016_j_biochi_2012_05_029
crossref_primary_10_1158_0008_5472_CAN_19_3670
crossref_primary_10_3389_fonc_2022_835290
crossref_primary_10_1016_j_dci_2008_10_006
crossref_primary_10_1038_s41375_018_0117_x
crossref_primary_10_1016_j_kint_2024_04_017
crossref_primary_10_1189_jlb_0608383
crossref_primary_10_1186_s12943_017_0736_2
crossref_primary_10_1038_s41419_021_04470_5
crossref_primary_10_1159_000353893
crossref_primary_10_1016_j_biocel_2021_106118
crossref_primary_10_1038_onc_2011_308
crossref_primary_10_1158_0008_5472_CAN_10_3304
crossref_primary_10_4049_jimmunol_0803721
crossref_primary_10_1371_journal_pone_0090275
crossref_primary_10_3389_fonc_2020_00612
crossref_primary_10_3724_SP_J_1206_2011_00196
crossref_primary_10_3389_fphys_2019_00500
crossref_primary_10_1007_s00262_020_02620_w
crossref_primary_10_1016_j_leukres_2007_11_035
crossref_primary_10_1111_j_1365_2559_2009_03290_x
crossref_primary_10_1155_2012_123253
crossref_primary_10_1038_s41375_021_01296_0
crossref_primary_10_1016_j_celrep_2016_09_018
crossref_primary_10_1002_cncr_26736
crossref_primary_10_1038_leu_2011_198
crossref_primary_10_1152_ajpregu_00632_2009
crossref_primary_10_1038_s41467_018_02890_0
crossref_primary_10_3390_genes11111336
crossref_primary_10_1371_journal_pone_0250499
crossref_primary_10_1053_j_seminoncol_2009_02_007
crossref_primary_10_3390_cells9010217
crossref_primary_10_1002_stem_470
crossref_primary_10_1002_hed_21586
crossref_primary_10_1016_j_semcdb_2016_02_009
crossref_primary_10_1007_s13277_013_1590_5
crossref_primary_10_1210_en_2006_0288
crossref_primary_10_1021_jm4018042
crossref_primary_10_1042_BST20150251
crossref_primary_10_3389_fphar_2020_01099
crossref_primary_10_1111_j_1365_2141_2006_06206_x
crossref_primary_10_3390_v13122514
crossref_primary_10_1182_blood_2006_04_016634
crossref_primary_10_1016_j_semcancer_2020_03_016
crossref_primary_10_4292_wjgpt_v1_i3_75
crossref_primary_10_3390_biom10081118
crossref_primary_10_3892_or_2013_2414
crossref_primary_10_18632_oncotarget_4054
crossref_primary_10_3390_v14112352
crossref_primary_10_1073_pnas_0907070106
crossref_primary_10_1016_j_clim_2017_12_001
crossref_primary_10_1073_pnas_1211805110
crossref_primary_10_1038_labinvest_3700696
crossref_primary_10_1038_nm1659
crossref_primary_10_1158_2326_6066_CIR_15_0061
crossref_primary_10_1016_j_biopha_2022_113323
crossref_primary_10_1093_abbs_gmaa109
crossref_primary_10_1021_cb700186x
crossref_primary_10_1002_jcb_24218
crossref_primary_10_18632_oncotarget_19932
crossref_primary_10_1016_j_canlet_2020_11_023
crossref_primary_10_1016_j_jhep_2014_03_017
crossref_primary_10_1182_blood_2005_08_007377
crossref_primary_10_3390_ijms25010331
crossref_primary_10_3390_ijms18061234
crossref_primary_10_1080_21623996_2014_999503
crossref_primary_10_1161_ATVBAHA_110_216200
crossref_primary_10_1038_ncomms10204
crossref_primary_10_1016_j_biocel_2017_10_002
crossref_primary_10_1158_0008_5472_CAN_07_6696
crossref_primary_10_1016_j_bbrc_2011_09_141
crossref_primary_10_1016_j_bbi_2014_04_008
crossref_primary_10_3892_or_2014_3098
crossref_primary_10_1002_stem_1746
crossref_primary_10_1172_JCI78488
crossref_primary_10_1007_s11523_012_0227_8
crossref_primary_10_3892_ijmm_2024_5379
crossref_primary_10_1016_j_bbrc_2014_01_086
crossref_primary_10_18632_oncotarget_23411
crossref_primary_10_1111_j_1471_4159_2008_05337_x
crossref_primary_10_1016_j_ejmech_2016_10_028
crossref_primary_10_3390_cells9061451
crossref_primary_10_1371_journal_pone_0099391
crossref_primary_10_1038_srep31690
crossref_primary_10_1016_j_humpath_2006_09_012
crossref_primary_10_1053_j_semdp_2019_12_002
crossref_primary_10_1177_2040620712471553
crossref_primary_10_1016_j_bcp_2005_12_017
crossref_primary_10_1158_0008_5472_CAN_09_2655
crossref_primary_10_1007_s00018_019_03095_4
crossref_primary_10_1182_blood_2009_05_219584
crossref_primary_10_1186_s12935_023_02899_6
crossref_primary_10_24287_1726_1708_2024_23_1_180_191
crossref_primary_10_3390_cancers6031408
crossref_primary_10_1038_leu_2009_91
crossref_primary_10_1038_cddis_2016_305
crossref_primary_10_1002_path_2990
crossref_primary_10_1007_s11033_014_3242_2
crossref_primary_10_1111_acel_13773
crossref_primary_10_1016_j_ydbio_2012_04_034
crossref_primary_10_2217_epi_10_51
crossref_primary_10_1007_s12026_009_8134_5
crossref_primary_10_1038_nrc1837
crossref_primary_10_1186_s13046_016_0301_7
crossref_primary_10_1038_s41417_018_0057_7
crossref_primary_10_2147_JIR_S459263
crossref_primary_10_1158_0008_5472_CAN_20_2297
crossref_primary_10_1016_j_cca_2012_05_007
crossref_primary_10_1016_j_biocel_2019_02_006
crossref_primary_10_1016_j_clim_2009_05_019
crossref_primary_10_1002_advs_202200169
crossref_primary_10_1038_s41577_019_0232_6
crossref_primary_10_3390_cimb46030156
crossref_primary_10_1016_j_jid_2018_03_1526
crossref_primary_10_3390_cancers11121930
crossref_primary_10_7314_APJCP_2015_16_6_2219
crossref_primary_10_1038_sj_jid_5701246
crossref_primary_10_1089_dna_2013_2042
crossref_primary_10_1200_JCO_2010_31_8907
crossref_primary_10_1080_08916930802024616
crossref_primary_10_3390_ijms19092708
crossref_primary_10_1007_s00109_010_0640_3
crossref_primary_10_4049_jimmunol_182_1_259
crossref_primary_10_1016_j_biopha_2020_111077
crossref_primary_10_1016_j_jneuroim_2012_03_003
crossref_primary_10_1016_j_leukres_2008_08_014
crossref_primary_10_1128_MCB_00467_08
crossref_primary_10_1038_labinvest_3700394
crossref_primary_10_1080_2162402X_2017_1333215
crossref_primary_10_1007_s00432_021_03519_4
crossref_primary_10_1182_blood_2006_04_017434
crossref_primary_10_2217_epi_14_18
crossref_primary_10_1186_ar3309
crossref_primary_10_1093_nar_gkv508
crossref_primary_10_1186_s13148_023_01436_6
crossref_primary_10_1016_j_ejmech_2012_08_024
crossref_primary_10_1002_bdrc_20163
crossref_primary_10_1038_cddis_2013_18
crossref_primary_10_1096_fj_202000600RR
crossref_primary_10_1182_blood_2006_11_058388
crossref_primary_10_3389_fimmu_2022_880315
crossref_primary_10_1517_14728222_10_1_157
crossref_primary_10_4161_jkst_22436
crossref_primary_10_3390_ijms222413571
crossref_primary_10_1210_en_2008_1142
crossref_primary_10_1016_j_abb_2022_109189
crossref_primary_10_3389_fimmu_2019_02634
crossref_primary_10_1007_s10620_012_2160_1
crossref_primary_10_1038_sj_leu_2404323
crossref_primary_10_1111_febs_16679
crossref_primary_10_3390_app11136192
crossref_primary_10_1093_hmg_dds403
crossref_primary_10_3390_ijms20092150
crossref_primary_10_1182_blood_2016_05_717793
crossref_primary_10_1111_febs_13285
crossref_primary_10_3390_cancers9080100
crossref_primary_10_1186_s12964_021_00747_6
crossref_primary_10_1007_s00109_005_0020_6
crossref_primary_10_1016_j_bbi_2019_01_013
crossref_primary_10_1128_MCB_05310_11
crossref_primary_10_4236_jct_2015_68078
crossref_primary_10_1007_s10875_013_9903_4
crossref_primary_10_1073_pnas_1100319108
Cites_doi 10.1038/nrg816
10.4049/jimmunol.168.1.466
10.1038/nrd772
10.4049/jimmunol.171.2.616
10.1038/sj.onc.1205152
10.1074/jbc.M001748200
10.1073/pnas.94.13.6764
10.1016/S0002-9440(10)64629-9
10.1074/jbc.274.36.25343
10.1126/science.1071545
10.1073/pnas.93.17.9148
10.1158/1541-7786.62.2.1
10.1038/nrc1275
10.1128/JVI.77.11.6385-6393.2003
10.1074/jbc.M309096200
10.1128/MCB.20.1.389-401.2000
10.1158/1535-7163.261.3.3
10.1128/MCB.23.17.6291-6299.2003
10.1038/ng1068
10.1016/S1097-2765(01)00199-X
10.1038/sj.onc.1206814
10.1182/blood-2003-06-2007
10.1056/NEJMra023075
10.1074/jbc.M301578200
10.1038/sj.onc.1205609
10.1038/77124
10.1182/blood.V95.3.745.003k05_745_755
10.1093/annonc/mdg216
10.1101/gad.1123303
10.1126/science.1065173
ContentType Journal Article
Copyright Copyright 1993/2005 The National Academy of Sciences of the United States of America
Copyright National Academy of Sciences May 10, 2005
Copyright © 2005, The National Academy of Sciences 2005
Copyright_xml – notice: Copyright 1993/2005 The National Academy of Sciences of the United States of America
– notice: Copyright National Academy of Sciences May 10, 2005
– notice: Copyright © 2005, The National Academy of Sciences 2005
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1073/pnas.0501959102
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
Ecology Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
Entomology Abstracts
Genetics Abstracts
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef

Virology and AIDS Abstracts


AIDS and Cancer Research Abstracts
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
EISSN 1091-6490
EndPage 6953
ExternalDocumentID 836473281
10_1073_pnas_0501959102
15870198
102_19_6948
3375461
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Research Support, N.I.H., Extramural
Feature
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA096856
– fundername: NCI NIH HHS
  grantid: R01 CA089194
– fundername: NCI NIH HHS
  grantid: R01 CA093371
– fundername: NCI NIH HHS
  grantid: R01-CA89194
– fundername: NCI NIH HHS
  grantid: R01-CA96856
– fundername: NCI NIH HHS
  grantid: P50-CA93371
GroupedDBID ---
-DZ
-~X
.55
.GJ
0R~
123
29P
2AX
2FS
2WC
3O-
4.4
53G
5RE
5VS
79B
85S
AACGO
AAFWJ
AANCE
AAYJJ
ABBHK
ABOCM
ABPLY
ABPPZ
ABTLG
ABXSQ
ABZEH
ACGOD
ACIWK
ACNCT
ACPRK
ADULT
ADZLD
AENEX
AEUPB
AEXZC
AFFNX
AFOSN
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AQVQM
ASUFR
AS~
BKOMP
CS3
D0L
DCCCD
DIK
DNJUQ
DOOOF
DU5
DWIUU
E3Z
EBS
EJD
F20
F5P
FRP
GX1
HH5
HQ3
HTVGU
HYE
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KQ8
L7B
LU7
MVM
N9A
NEJ
N~3
O9-
OK1
P-O
PNE
PQQKQ
R.V
RHF
RHI
RNA
RNS
RPM
RXW
SA0
SJN
TAE
TN5
UKR
VOH
VQA
W8F
WH7
WHG
WOQ
WOW
X7M
XFK
XSW
Y6R
YBH
YKV
YSK
ZA5
ZCA
ZCG
~02
~KM
-
02
0R
1AW
55
AAPBV
ABFLS
ABPTK
ADACO
AJYGW
AS
DZ
GJ
KM
OHM
PQEST
X
XHC
ADACV
CGR
CUY
CVF
ECM
EIF
H13
IPSME
NPM
AAYXX
CITATION
7QG
7QL
7QP
7QR
7SN
7SS
7T5
7TK
7TM
7TO
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c527t-9b31d441dab606945f29d658c697f821903b326104e3bd2d45bd11ca774043803
IEDL.DBID RPM
ISSN 0027-8424
IngestDate Tue Sep 17 21:26:06 EDT 2024
Sat Oct 26 05:59:26 EDT 2024
Fri Oct 25 07:31:17 EDT 2024
Thu Oct 10 17:10:21 EDT 2024
Fri Aug 23 00:57:27 EDT 2024
Sat Nov 02 12:28:57 EDT 2024
Wed Nov 11 00:29:19 EST 2020
Thu May 30 08:53:07 EDT 2019
Fri Feb 02 07:04:49 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 19
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c527t-9b31d441dab606945f29d658c697f821903b326104e3bd2d45bd11ca774043803
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Communicated by Peter C. Nowell, University of Pennsylvania School of Medicine, Philadelphia, PA, March 9, 2005
To whom correspondence should be addressed. E-mail: wasik@mail.med.upenn.edu.
Abbreviations: ALK+ TCL, T cell lymphoma expressing anaplastic lymphoma kinase; ChIP, chromatin immunoprecipitation; CTCL, cutaneous T-cell lymphoma; DNMT, DNA methyltransferase; HDAC, histone deacetylase; ON, oligonucleotide; PBMC; peripheral blood mononuclear cells; PHA-BL, phytohemagglutinin-activated T cell blasts; siRNA, small interfering RNA; STAT, signal transducer and activator of transcription.
Author contributions: Q.Z. and M.A.W. designed research; Q.Z., H.Y.W., M.M., P.N.R., and T.N. performed research; and M.A.W. wrote the paper.
OpenAccessLink https://europepmc.org/articles/pmc1100783?pdf=render
PMID 15870198
PQID 201379973
PQPubID 42026
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_1100783
pubmed_primary_15870198
pnas_primary_102_19_6948_fulltext
jstor_primary_3375461
proquest_miscellaneous_67821421
proquest_journals_201379973
proquest_miscellaneous_17622278
pnas_primary_102_19_6948
crossref_primary_10_1073_pnas_0501959102
ProviderPackageCode RNA
PNE
PublicationCentury 2000
PublicationDate 2005-05-10
PublicationDateYYYYMMDD 2005-05-10
PublicationDate_xml – month: 05
  year: 2005
  text: 2005-05-10
  day: 10
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
PublicationTitle Proceedings of the National Academy of Sciences - PNAS
PublicationTitleAlternate Proc Natl Acad Sci U S A
PublicationYear 2005
Publisher National Academy of Sciences
National Acad Sciences
Publisher_xml – name: National Academy of Sciences
– name: National Acad Sciences
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_20_2
e_1_3_2_21_2
e_1_3_2_22_2
(e_1_3_2_31_2) 2004; 3
e_1_3_2_23_2
e_1_3_2_24_2
e_1_3_2_25_2
(e_1_3_2_9_2) 2002; 306
(e_1_3_2_30_2) 2004; 2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_32_2
e_1_3_2_10_2
(e_1_3_2_13_2) 2002; 62
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_3_2
e_1_3_2_2_2
e_1_3_2_14_2
References_xml – ident: e_1_3_2_1_2
  doi: 10.1038/nrg816
– ident: e_1_3_2_6_2
  doi: 10.4049/jimmunol.168.1.466
– ident: e_1_3_2_29_2
  doi: 10.1038/nrd772
– ident: e_1_3_2_24_2
  doi: 10.4049/jimmunol.171.2.616
– ident: e_1_3_2_7_2
  doi: 10.1038/sj.onc.1205152
– volume: 62
  start-page: 6390
  year: 2002
  ident: e_1_3_2_13_2
  publication-title: Cancer Res.
– ident: e_1_3_2_16_2
  doi: 10.1074/jbc.M001748200
– ident: e_1_3_2_5_2
  doi: 10.1073/pnas.94.13.6764
– ident: e_1_3_2_12_2
  doi: 10.1016/S0002-9440(10)64629-9
– ident: e_1_3_2_20_2
  doi: 10.1074/jbc.274.36.25343
– ident: e_1_3_2_17_2
  doi: 10.1126/science.1071545
– ident: e_1_3_2_4_2
  doi: 10.1073/pnas.93.17.9148
– volume: 2
  start-page: 62
  year: 2004
  ident: e_1_3_2_30_2
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.62.2.1
– ident: e_1_3_2_8_2
  doi: 10.1038/nrc1275
– ident: e_1_3_2_32_2
  doi: 10.1128/JVI.77.11.6385-6393.2003
– ident: e_1_3_2_11_2
  doi: 10.1074/jbc.M309096200
– ident: e_1_3_2_18_2
  doi: 10.1128/MCB.20.1.389-401.2000
– volume: 3
  start-page: 261
  year: 2004
  ident: e_1_3_2_31_2
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.261.3.3
– ident: e_1_3_2_10_2
  doi: 10.1128/MCB.23.17.6291-6299.2003
– ident: e_1_3_2_21_2
  doi: 10.1038/ng1068
– ident: e_1_3_2_23_2
  doi: 10.1016/S1097-2765(01)00199-X
– ident: e_1_3_2_28_2
  doi: 10.1038/sj.onc.1206814
– ident: e_1_3_2_14_2
  doi: 10.1182/blood-2003-06-2007
– ident: e_1_3_2_3_2
  doi: 10.1056/NEJMra023075
– ident: e_1_3_2_25_2
  doi: 10.1074/jbc.M301578200
– ident: e_1_3_2_2_2
  doi: 10.1038/sj.onc.1205609
– volume: 306
  start-page: 1
  year: 2002
  ident: e_1_3_2_9_2
  publication-title: Gene.
– ident: e_1_3_2_15_2
  doi: 10.1038/77124
– ident: e_1_3_2_19_2
  doi: 10.1182/blood.V95.3.745.003k05_745_755
– ident: e_1_3_2_22_2
  doi: 10.1093/annonc/mdg216
– ident: e_1_3_2_26_2
  doi: 10.1101/gad.1123303
– ident: e_1_3_2_27_2
  doi: 10.1126/science.1065173
SSID ssj0009580
Score 2.3337157
Snippet Expression of SHP-1 phosphatase, a key negative regulator of cell signaling, is lost in T cell lymphomas and other malignancies due to DNA methylation of the...
SourceID pubmedcentral
proquest
crossref
pubmed
pnas
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6948
SubjectTerms Antibodies
Base Sequence
Binding sites
Biological Sciences
Blotting, Western
Cell Line, Tumor
Cell lines
Chromatin Immunoprecipitation
CpG Islands
DNA
DNA (Cytosine-5-)-Methyltransferase 1
DNA (Cytosine-5-)-Methyltransferases - metabolism
DNA Methylation
DNA Modification Methylases - metabolism
DNA-Binding Proteins - metabolism
Down-Regulation
Enzymes
Epigenetics
Gene Silencing
Genes
Histone Deacetylase 1
Histone Deacetylases - metabolism
Humans
Immunohistochemistry
Immunoprecipitation
Intracellular Signaling Peptides and Proteins
Lymphoma
Lymphoma, T-Cell - metabolism
Medical research
Methylation
Models, Genetic
Molecular Sequence Data
Polymerase chain reaction
Promoter Regions, Genetic
Protein Binding
Protein Tyrosine Phosphatase, Non-Receptor Type 6
Protein Tyrosine Phosphatases - metabolism
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger - metabolism
RNA, Small Interfering - metabolism
Signal transduction
STAT3 Transcription Factor
T cell lymphoma
T lymphocytes
T-Lymphocytes - enzymology
T-Lymphocytes - immunology
Trans-Activators - metabolism
Transfection
Title STAT3- and DNA Methyltransferase 1-Mediated Epigenetic Silencing of SHP-1 Tyrosine Phosphatase Tumor Suppressor Gene in Malignant T Lymphocytes
URI https://www.jstor.org/stable/3375461
http://www.pnas.org/content/102/19/6948.abstract
https://www.ncbi.nlm.nih.gov/pubmed/15870198
https://www.proquest.com/docview/201379973
https://search.proquest.com/docview/17622278
https://search.proquest.com/docview/67821421
https://pubmed.ncbi.nlm.nih.gov/PMC1100783
Volume 102
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9NAEB21PXFBFAo1hbJIHMphk6zXn8eoUAVQq0pNpd5WXu-aREpsq3YO-RX8ZWY2dkIQvXCztLPWWDOz81aeeQPwSYwK7ZtIcoPZgtN4bZ5arXlRJFZYYcLYDZu4vokm98H3h_DhAMK-F8YV7ed6PigXy0E5n7naynqZD_s6seHt9SXRnMWJHB7CITpof0XfMu0mm74TH4_fwA96Pp9YDusyawajkHrkMEu6QTZhQnzkyV5W2hQmEtspyv8Lef5dQPlHRrp6Ac87KMnGG5WP4cCWL-G4C9aGXXSM0p9fwa-76XgqOctKw77cjBmNjV4vWodZUaSxTHDXQoLwk9maCDqpt5E1c2pJwuTGqoLdTW65YO0aPwCRKatnVVPPspZ2t6tl9ciaVe2qavGRXsDmJVsiyv9JpTZsyhZrdJwqXyO2PYH7q6_TywnvJjHwPPTjlqdaCoPAyWQ6ok7ZsPBTg9glj9K4SPDQG0mNOBCvdlZq45sg1EaIPENs6Sjt5Ws4KqvSngIrsqCwOV5EZagDkQaZzRGBBQj7Yl_LyHpw0VtC1RvCDeV-lMdSkT3Uzn4enDhLbeUkzfONhAenTnK33VciVah34sHHp5ZU0VXbeHDWW1x1Ad0on6gZ0zSWHnzYrmIk0u-VrLTVqlEC8wo1Fj8tgcCAGO5QwTcb_9np0fmhB_GeZ20FiAV8fwWDw7GBd8Hw9r93nsEzx0frKGnfwVH7uLLvEWm1-hzvGN9-nLv4-g1wjCf3
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH4a4wAXxmBsYcCMxGEcktZxfh6rwVRgrSYtQ7tZceLQijaJluTQ_RP8yzw7SUsndoBbJD9HTvzZ77P83vcAPtBhJuzUY2aK3sJU5bXNUAphZlkgqaSp6-tiE5OpN752vt64Nzvg9rkwOmg_EXMrXyytfD7TsZXlMhn0cWKDy8mZkjnzAzZ4BI9xvQ6d_pC-1toN2swTGzdgx3Z6RR-fDco8rqyhq7Lk0E_qUjZuoBTJgy2_1IYmKr1TtP8b97wfQvmHTzrfg-_917ShKD-tphZWcndP6PGfP_c5POtYKhm1zfuwI_MXsN_tAxU57cSqP76EX1fRKGImifOUfJqOiKpIvVrUmg6jSSUJNXV2CjJbIkul_anSJkk1V9lO6DdJkZGr8aVJSb3CP4Okl5Szoipnca16182yuCVVU-qAXXxULyDznCzxAPFDRfGQiCxWiMkiWSFtPoDr88_R2djsijyYiWv7tRkKRlPkZGksPJWE62Z2mCItSrzQzwLcT4dMIMXEU6NkIrVTxxUppUmMtFWr5bNXsJsXuTwCksVOJhM84zJXODR0YpkguXOQUfq2YJ404LSfYl62Wh5c38H7jKuJ5htgGHCgIbC2Y6pUsEcNONKWm-42pyHHcQcGvH-oiWddII8Bxz2UeLdXVNxWqo9h6DMDTtatuMjVzU2cy6KpOEWXpXKWH7ZAzqHE83CAhy0wN-PoAG6AvwXZtYESGN9uQSBqofEOeK__u-cJPBlHkwt-8WX67RieatlbrXz7Bnbr20a-RUJXi3d6-f4GxohI6A
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Pb9MwFH6CISEuwGBsYcCMxGEc0tZxfh6rjar8WFVpnTRxseLYoRVtEi3JofwT_Ms8O0m7TuyyWyQ_R0782e-z_N73AD7RQSoc6TNborewdXltO1JC2GkaKqqo9AJTbOJi4o-v3G_X3vWtUl8maD8Ri162XPWyxdzEVharpN_FifWnF2da5iwIWb-Qaf8xPME1O_C7g_pGbzdssk8c3IRdx-1UfQLslcVlb-DpTDn0laacjRdqVfJwxzc14Yla8xTt_8c_74ZR3vJLoxfws_uiJhzld6-uRC_5c0fs8UGf_BKet2yVDBuTfXikslew3-4HJTltRas_v4a_l7PhjNkkziQ5nwyJrky9XlaGFqNJqQi1TZYKMlyiCq0BqtMnSbnQWU_oP0meksvx1KakWuPfQfJLinleFvO40r2repXfkLIuTOAuPuoXkEVGVniQ-KWjeciMLNeIzTxZI30-gKvRl9nZ2G6LPdiJ5wSVHQlGJXIzGQtfJ-N6qRNJpEeJHwVpiPvqgAmkmnh6VExIR7qekJQmMdJXo5rP3sBelmfqCEgau6lK8KzLPOHSyI1VgiTPRWYZOIL5yoLTbpp50Wh6cHMXHzCuJ5tvwWHBgYHBxo7pksE-teDIWG67O5xGHMcdWvDxviaetgE9Fhx3cOLtnlFyR6s_RlHALDjZtOJi1zc4cabyuuQUXZfOXb7fArmHFtHDAR424NyOowW5BcEObDcGWmh8twXBaATHW_C9fXDPE3g6PR_xH18n34_hmVG_NQK472CvuqnVe-R1lfhgVvA_BbJLaA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=STAT3-+and+DNA+Methyltransferase+1-Mediated+Epigenetic+Silencing+of+SHP-1+Tyrosine+Phosphatase+Tumor+Suppressor+Gene+in+Malignant+T+Lymphocytes&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Zhang%2C+Qian&rft.au=Wang%2C+Hong+Y.&rft.au=Marzec%2C+Michal&rft.au=Raghunath%2C+Puthiyaveettil+N.&rft.date=2005-05-10&rft.pub=National+Academy+of+Sciences&rft.issn=0027-8424&rft.eissn=1091-6490&rft.volume=102&rft.issue=19&rft.spage=6948&rft.epage=6953&rft_id=info:doi/10.1073%2Fpnas.0501959102&rft.externalDocID=3375461
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F102%2F19.cover.gif
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.pnas.org%2Fcontent%2F102%2F19.cover.gif